Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride effectively treats BPH, but needs more trials to understand potential.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Androgenetic alopecia in women needs more research and better management strategies.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Spironolactone plus finasteride reduces hirsutism more effectively.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Vertex pattern hair loss linked to higher prostate cancer risk.

Finasteride and minoxidil together promote hair growth better than either alone.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Men can report their own balding patterns well enough for large health studies.

Suppressing certain hormones might help prevent prostate cancer.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Higher DHT in male baldness may protect against prostate cancer.

Young women with PCOS and no other heart risk factors have normal heart function.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Finasteride and metformin both help treat PCOS, but using them together works best.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

PCOS has a strong genetic basis, but more research is needed to fully understand it.